NCT00465959已完成1 期
Safety, Tolerability, Pharmacokinetics, and Efficacy of Single Inhaled Administrations of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
Endo Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2007年4月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Safety and efficacy (measured by spirometry) of TrIP will be assessed in patients with chronic obstructive pulmonary disease.
研究概览
简要总结
To assess the effect of a single dose of TrIP on pulmonary function in patients with COPD
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 40 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female COPD patients between the ages of 40 and 80 years
- •Smoking history of at least 10 pack years
- •Not currently using (or able to wash out of) any long acting bronchodilators
排除标准
- •Candidate on a waiting list for surgery while on study
- •Using long-term oxygen therapy
- •Hospitalization for COPD exacerbation
研究组 & 干预措施
400 mg TrIP
Experimental
干预措施: trospium chloride inhalation powder (TrIP) (Drug)
800 mg TrIP
Experimental
干预措施: trospium chloride inhalation powder (TrIP) (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Safety and efficacy (measured by spirometry) of TrIP will be assessed in patients with chronic obstructive pulmonary disease.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study in Patients With COPDCOPDNCT00215449Dey690
已完成
4 期
Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)COPDNCT00996697Brian J Lipworth23
Unknown
1 期
Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPDOxygen Inhalation TherapyNCT01686893Medical University Innsbruck50
已完成
不适用
Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExamplePulmonary Disease, Chronic ObstructiveNCT01036763Boehringer Ingelheim
已完成
4 期
The Effect of Theophylline in the Treatment of BronchiectasisBronchiectasisNCT01684683The First Affiliated Hospital of Guangzhou Medical University100
